Tadalafil for erectile dysfunction: excellent safety and tolerance / 中华男科学杂志
National Journal of Andrology
;
(12): 92-95, 2009.
Article
in Chinese
| WPRIM
| ID: wpr-292418
ABSTRACT
As a novel phosphodiesterase type 5 (PDE5) inhibitor, tadalafil is administered orally for the treatment of erectile dysfunction (ED). In addition to its outstanding efficacy that lasts 36 hours, tadalafil shows an excellent safety and tolerance, with only a few transient mild to moderate adverse events. Usually ED patients are concomitantly afflicted with multiple pre-existing medical conditions or receive a range of drugs at the same time. Therefore, it is essential to understand its safety in general population and some special high-risk cohorts.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Phosphodiesterase Inhibitors
/
Carbolines
/
Therapeutic Uses
/
Drug Therapy
/
Drug Tolerance
/
Tadalafil
/
Erectile Dysfunction
Limits:
Humans
/
Male
Language:
Chinese
Journal:
National Journal of Andrology
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS